首页>
外国专利>
VIRUS-INACTIVATED BLOOD PLASMA OF UNIVERSAL CHANGE RECEIVED FROM PORTIONS OF PLASMA OF NON CAUCASOID RACE INDIVIDUALS
VIRUS-INACTIVATED BLOOD PLASMA OF UNIVERSAL CHANGE RECEIVED FROM PORTIONS OF PLASMA OF NON CAUCASOID RACE INDIVIDUALS
展开▼
机译:从非藻类个体的血浆中获得病毒活化的血浆的普遍变化
展开▼
页面导航
摘要
著录项
相似文献
摘要
FIELD: medicine.;SUBSTANCE: virus-inactivated blood plasma for introduction to the person, in essence, does not contain the agents inactivating viruses, received from donors from whom 10 % or more belong to population of the non-Caucasoid race individuals, thus plasma is received by mixing of blood or blood plasma of A and B groups, it is unessential AB, without adding blood or blood plasmas of the 0 group, and is characterised that it contains: from five to six parts of blood or a blood plasma of the donors having A group of blood, from four to five parts of blood or a blood plasma of the donors having B group of blood, from zero to one part of blood or a blood plasma of the donors having AB group of blood. The pharmaceutical composition for manufacture of a medical product for treatment of deficiencies of factors of coagulation, thrombocytopenic purpura is offered, and for use in a repeated exchange of great volume of plasma. Application a virus-inactivated blood plasma according to the invention for manufacture of a medical product and the way of a virus-inactivated blood plasma manufacture is offered.;EFFECT: rising of efficiency of treatment.;10 cl, 2 ex
展开▼
机译:领域:药物;物质:引入人的病毒灭活的血浆,实质上不包含从非高加索种族个体中有10%或更多的捐献者那里获得的灭活病毒的药剂血浆是通过将A组和B组的血液或血浆混合而得到的,它不是必需的AB,不添加0组的血液或血浆,其特征在于包含:五至六部分血液或血浆具有A组血液的献血者中,有B组血液的献血者的四到五份血液或血浆,具有AB组血液的献血者中有零至一血液或血浆。提供了用于制造用于治疗凝血因子缺乏症,血小板减少性紫癜的医疗产品的药物组合物,并且该药物组合物用于大量血浆的反复交换中。提供了根据本发明的病毒灭活的血浆在医疗产品的制造中的应用,以及提供了一种病毒灭活的血浆的制造方法。效果:治疗效率的提高; 10 cl,2 ex
展开▼